Accepted for Publication: June 10, 2022.
Published Online: August 15, 2022. doi:10.1001/jamaneurol.2022.2141
Corresponding Author: Xavier Ayrignac, MD, PhD, Department of Neurology, Montpellier University Hospital, 80 rue Augustin Fliche, 34295 Montpellier, Cedex 05, France (xavier.ayrignac@yahoo.fr).
Author Contributions: Dr Ayrignac had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Carra-Dalliere, Marelli, Taieb.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: Ayrignac, Carra-Dalliere, Marelli, Taieb.
Administrative, technical, or material support: Carra-Dalliere, Taieb, Labauge.
Supervision: Ayrignac, Marelli.
Conflict of Interest Disclosures: Dr Marelli reported board participation with Roche and travel grants from BioMarin Pharmaceutical and Nutricia outside the submitted work. No other disclosures were reported.
Additional Contributions: We thank Fanny Mochel, MD, PhD, and Romain Deschamps, MD, who provided MRIs of patients with X-ALD and biotinidase deficiency.
5.Flanagan
EP , Hinson
SR , Lennon
VA ,
et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients.
Ann Neurol. 2017;81(2):298-309. doi:
10.1002/ana.24881PubMedGoogle ScholarCrossref 10.Wells
E , Hacohen
Y , Waldman
A ,
et al; Attendees of the International Neuroimmune Meeting. Neuroimmune disorders of the central nervous system in children in the molecular era.
Nat Rev Neurol. 2018;14(7):433-445. doi:
10.1038/s41582-018-0024-9PubMedGoogle ScholarCrossref 12.Hardy
TA , Young
S , Sy
JS ,
et al. Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?
J Neurol Neurosurg Psychiatry. Published online August 9, 2017. doi:
10.1136/jnnp-2017-316142PubMedGoogle ScholarCrossref 13.Weisfeld-Adams
JD , Katz Sand
IB , Honce
JM , Lublin
FD . Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Brain. 2015;138(pt 3):517-539. doi:
10.1093/brain/awu397PubMedGoogle ScholarCrossref 17.Schindler
MK , Pittaluga
S , Enose-Akahata
Y ,
et al. Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder.
J Clin Invest. 2020;130(10):5551-5561. doi:
10.1172/JCI135947PubMedGoogle ScholarCrossref 18.Miller
WP , Mantovani
LF , Muzic
J ,
et al. Intensity of MRI gadolinium enhancement in cerebral adrenoleukodystrophy: a biomarker for inflammation and predictor of outcome following transplantation in higher risk patients.
AJNR Am J Neuroradiol. 2016;37(2):367-372. doi:
10.3174/ajnr.A4500PubMedGoogle ScholarCrossref 29.Kumar
AJ , Köhler
W , Kruse
B ,
et al. MR findings in adult-onset adrenoleukodystrophy.
AJNR Am J Neuroradiol. 1995;16(6):1227-1237.
PubMedGoogle Scholar 30.Mallack
EJ , Askin
G , van de Stadt
S ,
et al. A longitudinal analysis of early lesion growth in presymptomatic patients with cerebral adrenoleukodystrophy.
AJNR Am J Neuroradiol. 2021;42(10):1904-1911. doi:
10.3174/ajnr.A7250PubMedGoogle ScholarCrossref 31.Melhem
ER , Loes
DJ , Georgiades
CS , Raymond
GV , Moser
HW . X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression.
AJNR Am J Neuroradiol. 2000;21(5):839-844.
PubMedGoogle Scholar 36.Huffnagel
IC , van Ballegoij
WJC , van Geel
BM , Vos
JMBW , Kemp
S , Engelen
M . Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness.
Brain. 2019;142(2):334-343. doi:
10.1093/brain/awy299PubMedGoogle ScholarCrossref 37.Weisfeld-Adams
JD , Katz Sand
IB , Honce
JM , Lublin
FD . Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Brain. 2015;138(pt 3):517-539. doi:
10.1093/brain/awu397PubMedGoogle ScholarCrossref 39.Müller vom Hagen
J , Karle
KN , Schüle
R , Krägeloh-Mann
I , Schöls
L . Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients.
Eur J Neurol. 2014;21(7):983-988. doi:
10.1111/ene.12423PubMedGoogle ScholarCrossref 40.Benzoni
C , Moscatelli
M , Fenu
S , Venerando
A , Salsano
E . Metachromatic leukodystrophy with late adult-onset: diagnostic clues and differences from other genetic leukoencephalopathies with dementia.
J Neurol. 2021;268(5):1972-1976. doi:
10.1007/s00415-020-10374-9PubMedGoogle ScholarCrossref 41.Martin
A , Sevin
C , Lazarus
C , Bellesme
C , Aubourg
P , Adamsbaum
C . Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution.
AJNR Am J Neuroradiol. 2012;33(9):1731-1739. doi:
10.3174/ajnr.A3038PubMedGoogle ScholarCrossref 43.Xu
L , Zhong
M , Wang
Y ,
et al. Case report: novel arylsulfatase A (
ARSA) gene mutations in a patient with adult-onset metachromatic leukodystrophy misdiagnosed as multiple sclerosis.
Front Neurol. 2021;11:576881. doi:
10.3389/fneur.2020.576881PubMedGoogle ScholarCrossref 44.Boucher
AA , Miller
W , Shanley
R ,
et al. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
Orphanet J Rare Dis. 2015;10:94. doi:
10.1186/s13023-015-0313-yPubMedGoogle ScholarCrossref 46.Hoogeveen
ES , Pelzer
N , de Boer
I , van Buchem
MA , Terwindt
GM , Kruit
MC . Neuroimaging findings in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.
AJNR Am J Neuroradiol. 2021;42(9):1604-1609. doi:
10.3174/ajnr.A7194PubMedGoogle ScholarCrossref 49.Jacob
J , Robertson
NJ , Hilton
DA . The clinicopathological spectrum of Rosenthal fibre encephalopathy and Alexander’s disease: a case report and review of the literature.
J Neurol Neurosurg Psychiatry. 2003;74(6):807-810. doi:
10.1136/jnnp.74.6.807PubMedGoogle ScholarCrossref 52.Ayaki
T , Shinohara
M , Tatsumi
S , Namekawa
M , Yamamoto
T . A case of sporadic adult Alexander disease presenting with acute onset, remission and relapse.
J Neurol Neurosurg Psychiatry. 2010;81(11):1292-1293. doi:
10.1136/jnnp.2009.178079PubMedGoogle ScholarCrossref 63.Taieb
G , Mulero
P , Psimaras
D ,
et al; in cooperation with the French CLIPPERS Group. CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.
J Neurol Neurosurg Psychiatry. 2019;90(9):1027-1038. doi:
10.1136/jnnp-2018-318957PubMedGoogle ScholarCrossref 64.Tobin
WO , Guo
Y , Krecke
KN ,
et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).
Brain. 2017;140(9):2415-2425. doi:
10.1093/brain/awx200PubMedGoogle ScholarCrossref 71.Wiltink
RC , Kruijshaar
ME , van Minkelen
R ,
et al. Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations.
Eur J Hum Genet. 2016;24(10):1424-1429. doi:
10.1038/ejhg.2016.65PubMedGoogle ScholarCrossref 79.Codjia
P , Ayrignac
X , Mochel
F ,
et al. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: an MRI study of 16 French cases.
AJNR Am J Neuroradiol. 2018;39(9):1657-1661. doi:
10.3174/ajnr.A5744PubMedGoogle ScholarCrossref